- Efficiency of bevacizumab in treatment for relapsing ovarian cancer: case report2013 | First Faculty of Medicine
- Gemcitabine and carboplatin treatment in Patients with relapsing ovarian cancer2009 | Publication without faculty affiliation
- Gemcitabine and carboplatin treatment in Patients with relapsing ovarian cancer2009 | Central Library of Charles University
- Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial2020 | First Faculty of Medicine
- Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis2022 | First Faculty of Medicine
- Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: Outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status in the ORZORA trial2023 | First Faculty of Medicine
- ESPEN Guidelines on Parenteral Nutrition: Geriatrics2009 | First Faculty of Medicine
- Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial2022 | First Faculty of Medicine